Biora Therapeutics, Inc. (BIORQ) vs Valion Bio, Inc. (VBIO)
- Biora Therapeutics, Inc. BIORQ 0.00 NaN
- Valion Bio, Inc. VBIO 1.17 −4.88%
Biora Therapeutics, Inc. and Valion Bio, Inc. are both Biotechnology companies. Biora Therapeutics, Inc. and Valion Bio, Inc. are of similar size ($2.5M and $2.4M). Biora Therapeutics, Inc. grew revenue faster over the last twelve months: 347.0% against −49.6%. Valion Bio, Inc. has the higher net margin (0.00% vs −3,527.9%) and the lower return on invested capital (−61.0% vs 0.00%). Across the 16 metrics below, Biora Therapeutics, Inc. leads on 8 and Valion Bio, Inc. on 8.
Valuation
Profitability
| Metric | BIORQ | VBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 85.79% | (58.09%) | 65.16% |
| Operating margin | (6,809.06%) | 0.00% | 0.00% |
| Net margin | (3,527.85%) | 0.00% | 0.00% |
| Free cash flow margin | (5,165.88%) | 0.00% | 0.00% |
| Return on equity | 27.98% | (489.30%) | (56.36%) |
| Return on assets | (128.19%) | (104.96%) | (48.04%) |
| Return on invested capital | 0.00% | (61.01%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack